Do worse scores on patient-reported outcomes predict the progression of interstitial lung disease (ILD)?
Marlies S. Wijsenbeek, Paolo Spagnolo, Martin Kolb, Michael Kreuter, Hillario Nunes, Wibke Stansen, Klaus Rohr, Giichi Inoue
European Respiratory Journal 2021 58: PA3748; DOI: 10.1183/13993003.congress-2021.PA3748
Marlies S. Wijsenbeek
1Department of Respiratory Medicine, Erasmus MC, University Medical Centre, Rotterdam, Netherlands
Paolo Spagnolo
2Università degli Studi di Padova, Clinica di Malattie dell’Apparato Respiratorio, Padova, Italy
Martin Kolb
3McMaster University and St. Joseph’s Healthcare, Hamilton, Canada
Michael Kreuter
4Center for Interstitial and Rare Lung Diseases, Pneumology and Respiratory Care Medicine, Thoraxklinik, University of Heidelberg, Member of the German Center for Lung Research, Heidelberg, Germany
Hillario Nunes
5Department of Pulmonology, Hôpital Avicenne, APHP, Bobigny, France
Wibke Stansen
6Boehringer Ingelheim GmbH & Co. KG, Ingelheim am Rhein, Germany
Klaus Rohr
7Boehringer Ingelheim International GmbH, Ingelheim am Rhein, Germany
Giichi Inoue
8Clinical Research Center, National Hospital Organization Kinki-Chuo Chest Medical Center, Sakai City, Osaka, Osaka, Japan
Vol 58 Issue suppl 65
Table of Contents
Do worse scores on patient-reported outcomes predict the progression of interstitial lung disease (ILD)?
Marlies S. Wijsenbeek, Paolo Spagnolo, Martin Kolb, Michael Kreuter, Hillario Nunes, Wibke Stansen, Klaus Rohr, Giichi Inoue
European Respiratory Journal Sep 2021, 58 (suppl 65) PA3748; DOI: 10.1183/13993003.congress-2021.PA3748
Do worse scores on patient-reported outcomes predict the progression of interstitial lung disease (ILD)?
Marlies S. Wijsenbeek, Paolo Spagnolo, Martin Kolb, Michael Kreuter, Hillario Nunes, Wibke Stansen, Klaus Rohr, Giichi Inoue
European Respiratory Journal Sep 2021, 58 (suppl 65) PA3748; DOI: 10.1183/13993003.congress-2021.PA3748